fluoxetine and heroin

fluoxetine has been researched along with heroin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, KM; Gordon, L; Kosten, T; Nich, C; Petrakis, I; Rounsaville, B1
Bespalov, AY; Burakov, AM; Didenko, TY; Egorova, VY; Grinenko, AY; Ivanova, EB; Krupitsky, EM; Masalov, DV; Neznanov, NG; O'Brien, CP; Romanova, TN; Tsoy, MV; Verbitskaya, EV; Woody, GE; Zvartau, EE1
Ayranci, G; Befort, K; Chu-Sin-Chung, P; Filliol, D; Kieffer, BL; Koebel, P; Lutz, PE; Matifas, A; Ouagazzal, AM1
Ayranci, G; Befort, K; Filliol, D; Gavériaux-Ruff, C; Kieffer, BL; Lalanne, L; Lutz, PE1

Trials

2 trial(s) available for fluoxetine and heroin

ArticleYear
Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
    Drug and alcohol dependence, 1998, May-01, Volume: 50, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Depression; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Heroin; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Substance Abuse Detection; Treatment Outcome

1998
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Journal of substance abuse treatment, 2006, Volume: 31, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heroin; Heroin Dependence; HIV Infections; Humans; Male; Naltrexone; Narcotic Antagonists; Psychotherapy; Russia; Secondary Prevention; Substance Abuse, Intravenous; Substance Withdrawal Syndrome

2006

Other Studies

2 other study(ies) available for fluoxetine and heroin

ArticleYear
Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:11

    Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Disease Models, Animal; Dorsal Raphe Nucleus; Fluoxetine; Heroin; Heroin Dependence; Male; Memory Disorders; Memory, Short-Term; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Narcotics; Receptors, Opioid, kappa; Receptors, Opioid, mu; Social Behavior; Spatial Memory; Substance Withdrawal Syndrome

2014
Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.
    Addiction biology, 2017, Volume: 22, Issue:4

    Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Disease Models, Animal; Fluoxetine; Grooming; Heroin; Heroin Dependence; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Social Behavior; Time; Treatment Outcome

2017